/NIKA

NIKA Stock - Nika Pharmaceuticals Inc.

Q: What is the analyst price target for NIKA?

Analyst price target information is not currently available for NIKA.

Q: What is NIKA's market cap?

Market capitalization information is not currently available for NIKA.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.28+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.31

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NIKA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta64.50

52W High$1.00

52W Low$0.19

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-95,792	$-64,833	$-3,183,715	$-14,712	$-8,907
Net Income	$-95,792	$-64,833	$-3,183,715	$-14,712	$-8,907
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.00	$-0.00	$-0.00	$0.00	$0.00

Company Overview

Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

Visit Website

Frequently Asked Questions about NIKA

What is NIKA's current stock price?

Nika Pharmaceuticals Inc. (NIKA) is currently trading at $0.28 per share. The stock has moved +0.00% today.

What is the analyst price target for NIKA?

No analyst price targets are currently available for this stock.

What sector is Nika Pharmaceuticals Inc. in?

Nika Pharmaceuticals Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is NIKA's market cap?

Nika Pharmaceuticals Inc. has a market capitalization of $0.29 billion, making it a small-cap company.

Does NIKA pay dividends?

No, Nika Pharmaceuticals Inc. does not currently pay a dividend to shareholders.